Delving Even Deeper

18 December

April

Women, power, and the cancer divide, Michelle Bachelet (President of Chile), The Lancet, Vol. 389, No. 10071, p773–774

Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.  Jie-Bin Lew, Kate T Simms, Megan A Smith, Michaela Hall, Yoon-Jung Kang, Xiang Ming Xu, and others.  The Lancet Public Health, Vol. 2, No. 2, e96–e107

HPV vaccinations: a Middle Eastern and north African dilemma.  Hossein Bannazadeh Baghi, Bahman Yousefi, Mahin Ahangar Oskouee, Mohammad Aghazadeh.  The Lancet Infectious Diseases, Vol. 17, No. 1, p18–19

Expanding the benefits of HPV vaccination to boys and men. Liam Masterson, James O'Mahony, Matt Lechner.  The Lancet, Vol. 388, No. 10063, p2992

Balancing the cost–benefit equation for cervical cancer prevention: a moving target.  David G Regan, Basil Donovan. The Lancet Public Health, Vol. 1, No. 2, e42–e43

Changing global policy to deliver safe, equitable, and affordable care for women’s cancers. Ophira Ginsburg, Rajan Badwe, Peter Boyle, Gemma Derricks, Anna Dare, Tim Evans, and others. The Lancet, Vol. 389, No. 10071, p871–880

Women’s cancers: shining a light on a neglected health inequity. Udani Samarasekera, Richard Horton.  The Lancet, Vol. 389, No. 10071, p771–773

Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries. Lynette Denny, Silvia de Sanjose, Miriam Mutebi, Benjamin O Anderson, Jane Kim, Jose Jeronimo, and others.  The Lancet, Vol. 389, No. 10071, p861–870

Women, power, and the cancer divide.Michelle Bachelet. The Lancet

2016

Effect of HPV vaccination and cervical cancer screening in England by ethnicity: a modelling study, Helen C Johnson, Erin I Lafferty, Rosalind M Eggo, Karly Louie, Kate Soldan, Jo Waller, and others. The Lancet Public Health, Vol. 3, No. 1, e44–e51

Ethnic and racial disparities in cervical cancer: lessons from a modelling study of cervical cancer prevention,  Ophira Ginsburg, Electra D Paskett.  The Lancet Public Health, Vol. 3, No. 1, e8–e9

Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study.  Alejandra Castanon, Rebecca Landy, Francesca Pesola, Peter Windridge, Peter Sasieni  The Lancet Public Health, Vol. 3, No. 1, e34–e43

Accelerating cervical cancer control and prevention, Nicolas Wentzensen, Mark Schiffman, The Lancet Public Health, Vol. 3, No. 1, e6–e7

2017

9 July

Cervical cancer prevention for all women: Why now?  Vivien Davis Tsu. International Journal of Gynaecology and Obstetrics

Ending cervical cancer: A call to actionSanchia Aranda, Seth Berkley, Sally Cowal, Mark Dybul, Tim Evans, Katja Iversen, Matshidiso Moeti, Babatunde Osotimehin, Stefan Peterson, Peter Piot, Chittaranjan N. Purandare, Michel Sidibé, Ted Trimble, Vivien Davis Tsu. International Journal of Gynaecology and Obstetrics

Progress in HPV vaccination in low‐ and lower‐middle‐income countries. D. Scott LaMontagne, Paul J.N. Bloem, Julia M.L. Brotherton, Katherine E. Gallagher, Ousseynou Badiane, Cathy Ndiaye. International Journal of Gynaecology and Obstetrics

Optimizing secondary prevention of cervical cancer: Recent advances and future challengesGina Ogilvie, Carolyn Nakisige, Warner K. Huh, Ravi Mehrotra, Eduardo L. Franco, Jose Jeronimo. International Journal of Gynaecology and Obstetrics

Treatment of cervical intraepithelial lesions,  Philip E. Castle, Dan Murokora, Carlos Perez, Manuel Alvarez, Swee Chong Quek, Christine Campbell. International Journal of Gynaecology and Obstetrics

Management algorithms for cervical cancer screening and precancer treatment for resource‐limited settings.  Partha Basu, Filip Meheus, Youssef Chami, Roopa Hariprasad, Fanghui Zhao, Rengaswamy Sankaranarayanan. International Journal of Gynaecology and Obstetrics

Cervical cancer data and data systems in limited‐resource settings: Challenges and opportunities. Jennifer L. Drummond, Martin C. Were, Silvina Arrossi, Kara Wools‐Kaloustian. International Journal of Gynaecology and Obstetrics

Integrating cervical cancer screening and preventive treatment with family planning and HIV‐related services.  Heather L. White, Alejandra Meglioli, Raveena Chowdhury, Olivia Nuccio. International Journal of Gynaecology and Obstetrics

The health and economic impact of scaling cervical cancer prevention in 50 low‐ and lower‐middle‐income countries. Nicole G. Campos, Monisha Sharma, Andrew Clark, Kyueun Lee, Fangli Geng, Catherine Regan, Jane Kim, Stephen Resch. International Journal of Gynaecology and Obstetrics

Advocacy, communication, and partnerships: Mobilizing for effective, widespread cervical cancer prevention.  Scott Wittet, Jenny Aylward, Sally Cowal, Jacqui Drope, Etienne Franca, Sarah Goltz, Taona Kuo, Heidi Larson, Silvana Luciani, Emmanuel Mugisha, Celina Schocken, Julie Torode. International Journal of Gynaecology and Obstetrics

Scaling up proven innovative cervical cancer screening strategies: Challenges and opportunities in implementation at the population level in low‐ and lower‐middle‐income countries. Francesca Holme, Sharon Kapambwe, Ashrafun Nessa, Partha Basu, Raul Murillo, Jose Jeronimo. International Journal of Gynaecology and Obstetrics

The investment case for cervical cancer elimination. Vivien Davis Tsu Ophira Ginsburg. International Journal of Gynaecology and Obstetrics

Until eradication, awareness, Oliver S Jones, Claire Vassie, Richard Gilson, Matt Lechner, The Lancet Infectious Diseases, Vol. 17, No. 4, p368–369

HPV screening in Islamic countries, Murat Gültekin, Baki Akgül, The Lancet Infectious Diseases, Vol. 17, No. 4, p368

2018

24 March

New York Challenge sets high bar for HPV vaccination, Geoff Watts, The Lancet, Vol. 391, No. 10126, p1137   

Cervical cancer in India: neglected and stigmatized, Sophie Cousins, The Lancet Child & Adolescent Health, Vol. 2, No. 5, p314–315

Here are links to a selection of recently published papers about cervical cancer or HPV vaccination (most recent first). I’ve cited only freely available papers. NB If the link to the Lancet doesn’t work, you can register for free.

If you spend 30 minutes reading a sample of these papers, you’ll come away with a clear sense of how we stand at a time of historic opportunity. There are ways now to dramatically scale up HPV vaccination and to target screening more effectively (ie using HPV testing to identify women at risk) which would result in sharply reduced cervical cancer rates in the years ahead. And save the lives of millions of women.

Cancer Research UK
In aid of:

Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666) and the Isle of Man (1103). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: Angel Building, 407 St John Street, London EC1V 4AD.

facebook share
Laurence Carter Instagram
linkedin-teal.png
twitter share
3500toendit - YouTube channel